ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2216

Cardiovascular Risk Assessment in Spondyloarthritis Using the Score Chart and Reclassification by Presence of Plaques On Ultrasonography

Jl Rosales-Alexander1, Juan Salvatierra1, César Magro Checa1, Jesús Cantero Hinojosa2 and Enrique Raya Álvarez1, 1Rheumatology, University Hospital San Cecilio, Granada, Spain, 2Internal Medicine, University Hospital San Cecilio, Granada, Spain

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Cardiovascular disease, inflammation and spondylarthropathy

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Spondylarthropathies and Psoriatic Arthritis: Clinical Aspects and Treatment

Session Type: Abstract Submissions (ACR)

Background/Purpose: Increased cardiovascular (CV) risk have been described in patients with rheumatic diseases including spondyloarthritis (SpA). Besides traditional CV risk factors, disease specific factors have been suggested as possible etiologic factors for atherosclerosis. Increased carotid Intima-media thickness (IMT) has been found to be increased in rheumatic diseases. In RA and other inflammatory arthritis, EULAR recommends annual CV risk assessment according to national guidelines, but there is not a calibrated SCORE chart for SpA patients. 

Objectives: To asses CV risk in SpA patients using the SCORE chart calibrated for Spain (SCOREm) and to determine the percentage of patients  reclassified according to the presence of plaques by the use of common carotid artery (CCA) ultrasonography (US). To analyse the factors that predict a higher global CV risk. 

Methods: All patients with SpA, fulfilling the “Assessment of SpondyloArthritis international Society” (ASAS) classification criteria, without previous ischemic events were prospectively included in a database, containing demographic and clinical information. For the study, 90 living spanish patients were selected. Classic CV risk factors, acute phase reactants (APR), disease activity indexes and lipid profile were obtained. CV risk was calculated using the SCOREm and the presence of plaques – measure of the CCA IMT was evaluated by B-doppler US.  Chi-square or McNemar`s tests were used to assess differences between qualitative variables, and ANOVA with Bonferroni adjustment for comparing means. Factors predicting higher global CV risk were evaluated by multivariate lineal regression analysis.

Results: Most patients (54%) were men, 77% were HLA-B27 positive. Mean age was 46,32±14,4 years and mean disease duration was 8,8±6,8 years. Mean SCOREm was 1,3±2,7. Low CV risk was found in 64(71%) patients, intermediate, high and very high risk in 23(25,7%), 2 (2,2%) and 1(1,1%) patients respectively. After CCA US was performed, plaques were found in 10/90(11,1 %) patients. Of these, reclassification to high risk was done in 3 and 5 patients with low and intermediate risk respectively (p<0,001). Mean IMT was 0,61±0,11 mm. Higher global CV risk was predicted by hypertension (β 3,66; p=0,00), dyslipidemia (β -1,77; p=0,016), time of disease (β 0,075; p=0,040) and HLA-B7 positivity (β -1,82; p=0,002).

Conclusion: In our study most SpA patients have low and intermediate CV risk using the SCOREm chart, but after performing CCA US 8(8,9%) patients were  reclassified into high risk by the presence of plaques. Besides  classic CV risk factors, some disease characteristics might contribute to the expression of higher global CV risk in these patients.


Disclosure:

J. Rosales-Alexander,
None;

J. Salvatierra,
None;

C. Magro Checa,
None;

J. Cantero Hinojosa,
None;

E. Raya Álvarez,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cardiovascular-risk-assessment-in-spondyloarthritis-using-the-score-chart-and-reclassification-by-presence-of-plaques-on-ultrasonography/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology